journal cover

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures

Acta Neurologica Scandinavica

Oct 17, 2009

Antonio Gil-NagelBIA-2093-303 Investigators Study Group

Abstract

To evaluate the efficacy and safety of eslicarbazepine acetate (ESL) as adjunctive therapy in adults with partial-onset seizures. Double-blind, placebo-controlled, parallel-group, multicenter study consisting of an 8-week baseline period, after which patients were randomized to placebo ...read more

Mentioned in this Paper

Anticonvulsants
Orthostasis
Selection of Subjects
Adverse Event
Benign Occipital Epilepsy
Compound A 12
Dizziness
Nausea
Vertex Headache
Non-epileptic Convulsion
45
Paper Details
References
  • References11
  • Citations71
12
  • References11
  • Citations71
12345...

Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures

Acta Neurologica Scandinavica

Oct 17, 2009

Antonio Gil-NagelBIA-2093-303 Investigators Study Group

PMID: 19832771

DOI: 10.1111/j.1600-0404.2009.01218.x

Abstract

To evaluate the efficacy and safety of eslicarbazepine acetate (ESL) as adjunctive therapy in adults with partial-onset seizures. Double-blind, placebo-controlled, parallel-group, multicenter study consisting of an 8-week baseline period, after which patients were randomized to placebo ...read more

Mentioned in this Paper

Anticonvulsants
Orthostasis
Selection of Subjects
Adverse Event
Benign Occipital Epilepsy
Compound A 12
Dizziness
Nausea
Vertex Headache
Non-epileptic Convulsion
45

Related Papers

Paper Details
References
  • References11
  • Citations71
12
  • References11
  • Citations71
12345...
/papers/efficacy-and-safety-of-800-and-1200-mg/19832771